R&D Intelligence
$85B
Market TAM
8.5%
CAGR
12%
Phase I PoS
$2.5M
IND Budget
+24%
Pipeline Growth
▲ vs last quarter
47
Active Trials
Phase II-III
3.2x
ROI Potential
5-year outlook
Complementary

NADDBio R&D Insights Report

Weeks of research. Minutes to deliver.

AI-powered strategic analysis for biopharma companies - from discovery through post-marketing. Complete a 2-minute questionnaire and receive your personalized WipBoard.

Powered by curated AI research tools, saving weeks of consulting research. Need execution support? Our team can help.

What You Get

Intelligence in minutes, not weeks

Interactive Dashboard

D3.js visualizations of competitive landscape, timelines, trial sites, and budget allocation.

Strategic Brief

Executive narrative with implementation roadmap, partner recommendations, and regulatory guidance.

Expert Analysis

Deep market research across Clinical Development, Regulatory, Pharmacovigilance, and Medical Affairs.

NADDBio Expertise

24+ years of pharma medicine experience across Oncology, Cardio-Metabolism, Immunology, and more.

Who It's For

  • Biotech startups planning clinical development strategy
  • Pharmaceutical companies evaluating pipeline assets
  • Venture capital firms conducting due diligence
  • Academic spin-outs commercializing research
  • CROs supporting client development programs

How It Works

Complete Questionnaire

Answer 9 simple fields about your therapeutic area, development phase, and strategic priorities. Takes just 2 minutes.

AI Analysis

Our system analyzes your inputs against comprehensive market data, regulatory intelligence, and competitive landscapes.

Receive Dashboard

Get your personalized R&D Intelligence Dashboard within minutes - complete with interactive charts and strategic recommendations.

Get in Touch

Ready to accelerate your drug development? Contact us for consulting, regulatory guidance, or R&D Insights questions.

Send Us a Message